Injection-site granulomas resulting from the administration of both leuprorelin acetate and goserelin acetate for the treatment of prostatic cancer

Journal of Nippon Medical School

Volumn 74, Issue 4, 2007, Pages 306-308

  Shiota, Masaki ^a,b   Tokuda, Noriaki ^a   Kanou, Takehiro ^a   Yamasaki, Humio ^a  

^a Saga Prefectural Hospital   (Japan)

^b Saga Prefectural Hospital   (Japan)

Author keywords

Goserelin acetate; Granuloma; Leuprorelin acetate; Luteinizing hormone releasing hormone analogue; Prostatic neoplasms

Indexed keywords

CD68 ANTIGEN; GOSERELIN; LEUPRORELIN;

AGED; ARTICLE; BIOPSY; CASE REPORT; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GRANULOMA; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGENICITY; INJECTION SITE GRANULOMA; INJECTION SITE REACTION; MALE; PROSTATE CANCER; SUBCUTANEOUS NODULE; SURGICAL TECHNIQUE; T LYMPHOCYTE;

AGED, 80 AND OVER; GOSERELIN; GRANULOMA; HUMANS; INJECTIONS; LEUPROLIDE; MALE; PROSTATIC NEOPLASMS;

EID: 34548161952     PISSN: 13454676     EISSN: 13473409     Source Type: Journal    
DOI: 10.1272/jnms.74.306     Document Type: Article

References (4)

1. Fawcett HA, Smith NP: Injection-site granuloma due to aluminum. Arch Dermatol 1984; 120: 1318-1322.
2. Saxby M: Leuprorelin acetate granulomas: recurrent subcutaneous nodules mimicking metastatic deposits at injection sites.; letters to editor. BJU Int 2003; 91: 125.
3. Whitaker IS, Fazel HB: Leuprorelin acetate granulomas: recurrent subcutaneous nodules mimicking metastatic deposits at injection sites. BJU Int 2002; 90: 350.
4. Yasukawa K, Sawamura D, Sugawara H, Kato N: Leuprorelin acetate granulomas: case reports and review of the literature. Br J Dermatol 2005; 152: 1045-1047.